0001225208-18-004949.txt : 20180301
0001225208-18-004949.hdr.sgml : 20180301
20180301163713
ACCESSION NUMBER: 0001225208-18-004949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180301
DATE AS OF CHANGE: 20180301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pierce David A
CENTRAL INDEX KEY: 0001529751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 18658000
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2018-02-28
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001529751
Pierce David A
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP,Pres Urology,Pelvic Health
Common Stock
2018-02-28
4
M
0
4398.0000
0.0000
A
33107.0000
D
Common Stock
2018-02-28
4
M
0
2443.0000
0.0000
A
35550.0000
D
Common Stock
2018-02-28
4
F
0
3041.0000
27.2600
D
32509.0000
D
Common Stock
2018-02-28
4
S
0
4508.0000
27.5445
D
28001.0000
D
Deferred Stock Units
2018-02-28
4
M
0
4398.0000
0.0000
D
2018-02-28
Common Stock
4398.0000
0.0000
D
Deferred Stock Units
2018-02-28
4
M
0
2443.0000
0.0000
D
2022-02-28
Common Stock
2443.0000
9776.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at $27.52 and $27.575. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
/s/ Vance R. Brown, Attorney-in-fact
2018-03-01